Cuprina Holdings Cayman Limited Receivables Turnover Ratio (CUPR), from the fourth quarter 2025 to the fourth quarter 2024 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Cuprina Holdings cayman Limited  (NASDAQ: CUPR)
 

Cuprina Holdings Cayman Limited Accounts Receivables Turnover Ratio from the fourth quarter 2025 to the fourth quarter 2024

Quarterly Results, Trends, Rankings, Statistics


Cuprina Holdings Cayman Limited's ability to collect accounts receivable sequentially worsen to 1.2, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Cuprina Holdings Cayman Limited's Accounts Receivable average collection period in the Dec 31 2025 quarter, has increased to 304 days, from 297 days, in the 0 quarter.

If we take a look into Healthcare sector 566 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3819, from overall ranking in the third quarter 2025 at 3885.

What is Receivable Turnover Ratio?
What is Cuprina Holdings Cayman Limited Selling?


What is Receivable Turnover Ratio?





CUPR Receivables Turnover Ratio (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Receivable Change 37.07 % -26.99 % 150.28 % -26.99 % -
Y / Y Revenue Change 9.2 % - - - -
Receivable Turnover Ratio (TTM) 1.2 1.23 1.18 1.56 1.47
CUPR's Total Ranking # 3819 # 3885 # # #
Accounts Receivable average collection period days 304 296 309 234 248
Seq. Receivable Change 269.77 % -70.83 % 242.8 % -62.93 % 96.96 %
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 186
Healthcare Sector # 567
Overall Market # 3819

Receivable Turnover Ratio Statistics
High Average Low
1.83 1.52 1.2
(Dec 31 2024)   (Dec 31 2025)






Financial Statements
Cuprina Holdings Cayman Limited's Accounts Receivable $ 0 Millions Visit CUPR's Balance sheet
Cuprina Holdings Cayman Limited's Sales TTM $ 0 Millions Visit CUPR's Income Statement
Sources of CUPR's Revenues Visit CUPR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CUPR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CUPR's Growth Rates CUPR's Roa CUPR's Inventory Turnover Ratio CUPR's Dividend Comparisons
CUPR's Profitability Ratios CUPR's Roi CUPR's Asset Turnover Ratio CUPR's Dividend Growth
CUPR's Valuation Ratios CUPR's Roe CUPR's Financial Strength Ratios CUPR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Receivable at quarter ending Dec 31 2025
Marker Therapeutics inc   1.98 $ 3.547  Millions$ 1.792  Millions
Grifols Sa  1.91 $ 8,426.880  Millions$ 4,420.640  Millions
Aytu Biopharma Inc  1.89 $ 61.870  Millions$ 32.782  Millions
Hyperfine Inc   1.89 $ 12.753  Millions$ 6.762  Millions
Heron Therapeutics Inc   1.88 $ 154.557  Millions$ 82.325  Millions
Biocorrx Inc   1.84 $ 0.797  Millions$ 0.433  Millions
Coherus Oncology inc   1.82 $ 42.172  Millions$ 23.164  Millions
Ocular Therapeutix Inc   1.78 $ 51.951  Millions$ 29.263  Millions
Cardiff Oncology Inc   1.74 $ 0.593  Millions$ 0.342  Millions
Ascendis Pharma A  1.63 $ 806.548  Millions$ 496.010  Millions
Co diagnostics Inc   1.59 $ 0.622  Millions$ 0.390  Millions
Amarin Corp Plcuk  1.59 $ 213.646  Millions$ 134.765  Millions
Oculis Holding Ag  1.53 $ 1.199  Millions$ 0.785  Millions
Cardio Diagnostics Holdings Inc   1.42 $ 0.015  Millions$ 0.010  Millions
Sinovac Biotech Ltd  1.35 $ 385.981  Millions$ 286.344  Millions
Dianthus Therapeutics Inc   1.34 $ 2.036  Millions$ 1.523  Millions
Regen Biopharma Inc   1.28 $ 0.237  Millions$ 0.184  Millions
Hcw Biologics Inc   1.26 $ 0.054  Millions$ 0.043  Millions
Assertio Holdings inc   1.22 $ 118.713  Millions$ 97.200  Millions
Cuprina Holdings cayman Limited  1.20 $ 0.039  Millions$ 0.032  Millions
Onemednet Corporation  1.17 $ 0.461  Millions$ 0.394  Millions
Intercure Ltd   1.09 $ 270.200  Millions$ 246.803  Millions
Rafael Holdings Inc  1.08 $ 0.770  Millions$ 0.715  Millions
Skinvisible Inc   0.93 $ 0.020  Millions$ 0.021  Millions
Silence Therapeutics Plc  0.81 $ 0.559  Millions$ 0.690  Millions
Nyxoah Sa  0.80 $ 11.085  Millions$ 13.842  Millions
Meihua International Medical Technologies Co Ltd  0.70 $ 61.792  Millions$ 88.118  Millions
Prokidney Corp   0.61 $ 0.893  Millions$ 1.473  Millions
Cardiff Lexington Corporation  0.58 $ 11.536  Millions$ 19.867  Millions
Biolinerx Ltd   0.51 $ 1.180  Millions$ 2.324  Millions

Date modified: 2026-07-07T10:14:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.